Market Report, "Bulgaria Pharmaceuticals & Healthcare Report Q3 2013", Published
According to industry sources, the Bulgarian pharmaceuticals market has reached a standstill. This is expected to continue throughout 2013, due to the decline in drug prices and the stagnant health insurance fund budget. We expect that the market will post single-digit value increase, on account of inflationary pressures and continued volume demand. Political uncertainty will also add to the negative pressures affecting the wider healthcare market.
View full press release